Lilly (China)

296 papers and 5.8k indexed citations i.

About

In recent decades, authors affiliated with Lilly (China) have published 296 papers, which have received a total of 5.8k indexed citations. Scholars at this organization have produced 69 papers in Endocrinology, Diabetes and Metabolism, 65 papers in Oncology and 58 papers in Pulmonary and Respiratory Medicine on the topics of Diabetes Treatment and Management (57 papers), Diabetes Management and Research (41 papers) and Lung Cancer Treatments and Mutations (39 papers). Their work is cited by papers focused on Molecular Biology (1.5k citations), Surgery (1.4k citations) and Endocrinology, Diabetes and Metabolism (1.1k citations). Authors at Lilly (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Cell, JAMA and Chemical Society Reviews. Some of Lilly (China)'s most productive authors include Hua Lin, Susan M. Reutzel‐Edens, Shouhong Xuan, Domenico Accili, Lori Sussel, Joel Bernstein, Aurora J. Cruz‐Cabeza, Lawrence B. Mohr, H.‐J. Mest and Rolf Mentlein.

In The Last Decade

Fields of papers published by authors at Lilly (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Lilly (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Lilly (China) at the time of their publication.

Countries citing scholars working at Lilly (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Lilly (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Lilly (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025